{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T15:32:53Z","timestamp":1791300773331,"version":"4.1.0"},"reference-count":48,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2014,4,9]],"date-time":"2014-04-09T00:00:00Z","timestamp":1397001600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0094092","type":"journal-article","created":{"date-parts":[[2014,4,9]],"date-time":"2014-04-09T20:58:03Z","timestamp":1397077083000},"page":"e94092","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":46,"title":["Opposite Effects of Gene Deficiency and Pharmacological Inhibition of Soluble Epoxide Hydrolase on Cardiac Fibrosis"],"prefix":"10.1371","volume":"9","author":[{"given":"Lijuan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce D.","family":"Hammock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ding","family":"Ai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,4,9]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1172\/JCI31044","article-title":"ECM remodeling in hypertensive heart disease","volume":"117","author":"BC Berk","year":"2007","journal-title":"J Clin Invest"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0025-7125(03)00168-8","article-title":"Cardiac remodeling in systemic hypertension","volume":"88","author":"S Kenchaiah","year":"2004","journal-title":"Med Clin North Am"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.yexcr.2004.10.009","article-title":"Nesprin-1alpha contributes to the targeting of mAKAP to the cardiac myocyte nuclear envelope","volume":"303","author":"GC Pare","year":"2005","journal-title":"Exp Cell Res"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.pharmthera.2009.05.002","article-title":"Cardiac fibroblasts: at the heart of myocardial remodeling","volume":"123","author":"KE Porter","year":"2009","journal-title":"Pharmacol Ther"},{"key":"ref5","first-page":"286","article-title":"Colocalization of myocardial fibrosis and inflammatory cells in rats","volume":"70","author":"N Hinglais","year":"1994","journal-title":"Lab Invest"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1161\/01.CIR.0000092890.29552.22","article-title":"Anti-monocyte chemoattractant protein-1 gene therapy attenuates left ventricular remodeling and failure after experimental myocardial infarction","volume":"108","author":"S Hayashidani","year":"2003","journal-title":"Circulation"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1161\/CIRCULATIONAHA.111.052126","article-title":"Regulatory role of dendritic cells in postinfarction healing and left ventricular remodeling","volume":"125","author":"A Anzai","year":"2012","journal-title":"Circulation"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1006\/jaut.2000.0432","article-title":"Chronic myocarditis induced by T cells reactive to a single cardiac myosin peptide: persistent inflammation, cardiac dilatation, myocardial scarring and continuous myocyte apoptosis","volume":"15","author":"NR Ratcliffe","year":"2000","journal-title":"J Autoimmun"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1161\/HYPERTENSIONAHA.111.174748","article-title":"Mast cells and cardiac fibroblasts: accomplices in elevation of collagen synthesis in modulation of fibroblast phenotype","volume":"58","author":"IM Dixon","year":"2011","journal-title":"Hypertension"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"641","DOI":"10.4049\/jimmunol.178.2.641","article-title":"Arachidonic acid metabolism as a potential mediator of cardiac fibrosis associated with inflammation","volume":"178","author":"SP Levick","year":"2007","journal-title":"J Immunol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1038\/nrd2875","article-title":"Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases","volume":"8","author":"JD Imig","year":"2009","journal-title":"Nat Rev Drug Discov"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/0090-6980(89)90124-X","article-title":"Arachidonic acid metabolites by cytochrome P-450 dependent monooxygenase pathway in bovine adrenal fasciculata cells","volume":"38","author":"M Nishimura","year":"1989","journal-title":"Prostaglandins"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1073\/pnas.79.3.767","article-title":"Cytochrome P-450-dependent oxygenation of arachidonic acid to hydroxyicosatetraenoic acids","volume":"79","author":"J Capdevila","year":"1982","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"R166","DOI":"10.1186\/cc11518","article-title":"Eliminating or blocking 12\/15-lipoxygenase reduces neutrophil recruitment in mouse models of acute lung injury","volume":"16","author":"J Rossaint","year":"2012","journal-title":"Crit Care"},{"key":"ref15","first-page":"491","article-title":"Modulation of human neutrophil function by monohydroxy-eicosatetraenoic acids","volume":"39","author":"EJ Goetzl","year":"1980","journal-title":"Immunology"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0090-6980(80)90155-0","article-title":"Unique aspects of the modulation of human neutrophil function by 12-L-hydroperoxy-5,8,10,14-eicosatetraenoic acid","volume":"19","author":"EJ Goetzl","year":"1980","journal-title":"Prostaglandins"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2174\/187152312803305759","article-title":"A Novel Treatment Strategy for Sepsis and Septic Shock Based on the Interactions between Prostanoids, Nitric Oxide, and 20-Hydroxyeicosatetraenoic Acid","volume":"11","author":"B Tunctan","year":"2012","journal-title":"Antiinflamm Antiallergy Agents Med Chem"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.phrs.2009.12.015","article-title":"Alteration of cardiac cytochrome P450-mediated arachidonic acid metabolism in response to lipopolysaccharide-induced acute systemic inflammation","volume":"61","author":"A Anwar-mohamed","year":"2010","journal-title":"Pharmacol Res"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/ki.2010.377","article-title":"Inhibition of 20-HETE synthesis and action protects the kidney from ischemia\/reperfusion injury","volume":"79","author":"U Hoff","year":"2011","journal-title":"Kidney Int"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0163-7827(03)00049-3","article-title":"Epoxyeicosatrienoic acids (EETs): metabolism and biochemical function","volume":"43","author":"AA Spector","year":"2004","journal-title":"Prog Lipid Res"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.yjmcc.2009.10.022","article-title":"Cytochrome P450 epoxygenases, soluble epoxide hydrolase, and the regulation of cardiovascular inflammation","volume":"48","author":"Y Deng","year":"2010","journal-title":"J Mol Cell Cardiol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/FJC.0b013e3181506445","article-title":"The soluble epoxide hydrolase as a pharmaceutical target for hypertension","volume":"50","author":"N Chiamvimonvat","year":"2007","journal-title":"J Cardiovasc Pharmacol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"18733","DOI":"10.1073\/pnas.0609158103","article-title":"Prevention and reversal of cardiac hypertrophy by soluble epoxide hydrolase inhibitors","volume":"103","author":"D Xu","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1074\/jbc.M608057200","article-title":"Compensatory mechanism for homeostatic blood pressure regulation in Ephx2 gene-disrupted mice","volume":"282","author":"A Luria","year":"2007","journal-title":"J Biol Chem"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1073\/pnas.0811022106","article-title":"Soluble epoxide hydrolase plays an essential role in angiotensin II-induced cardiac hypertrophy","volume":"106","author":"D Ai","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"40504","DOI":"10.1074\/jbc.M008106200","article-title":"Targeted disruption of soluble epoxide hydrolase reveals a role in blood pressure regulation","volume":"275","author":"CJ Sinal","year":"2000","journal-title":"J Biol Chem"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0008-6363(99)00057-7","article-title":"Cultured neonatal rat cardiac myocytes and fibroblasts do not synthesize renin or angiotensinogen: evidence for stretch-induced cardiomyocyte hypertrophy independent of angiotensin II","volume":"43","author":"CA van Kesteren","year":"1999","journal-title":"Cardiovasc Res"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1002\/hep.25778","article-title":"Pentoxifylline decreases oxidized lipid products in nonalcoholic steatohepatitis: New evidence on the potential therapeutic mechanism","volume":"56","author":"CO Zein","year":"2012","journal-title":"Hepatology"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.prostaglandins.2011.11.003","article-title":"15-Hydroxyeicosatetraenoic acid (15-HETE) protects pulmonary artery smooth muscle cells from apoptosis via inducible nitric oxide synthase (iNOS) pathway","volume":"97","author":"X Nie","year":"2012","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"22478","DOI":"10.1074\/jbc.M111.225060","article-title":"15-Lipoxygenase-1-enhanced Src-Janus kinase 2-signal transducer and activator of transcription 3 stimulation and monocyte chemoattractant protein-1 expression require redox-sensitive activation of epidermal growth factor receptor in vascular wall remodeling","volume":"286","author":"NK Singh","year":"2011","journal-title":"J Biol Chem"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1161\/01.HYP.36.4.610","article-title":"Cytochrome P450-dependent renal arachidonic acid metabolism in desoxycorticosterone acetate-salt hypertensive mice","volume":"36","author":"H Honeck","year":"2000","journal-title":"Hypertension"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1111\/bph.12066","article-title":"Soluble epoxide hydrolase inhibitor, TUPS, protects against isoprenaline-induced cardiac hypertrophy","volume":"168","author":"HN Althurwi","year":"2013","journal-title":"Br J Pharmacol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1126\/science.285.5431.1276","article-title":"Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids","volume":"285","author":"K Node","year":"1999","journal-title":"Science"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.cmet.2005.08.005","article-title":"Prostacyclin protects against elevated blood pressure and cardiac fibrosis","volume":"2","author":"H Francois","year":"2005","journal-title":"Cell Metab"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1006\/jmcc.1995.0236","article-title":"Chronic aspirin treatment affects collagen deposition in non-infarcted myocardium during remodeling after coronary artery ligation in the rat","volume":"27","author":"EA Kalkman","year":"1995","journal-title":"J Mol Cell Cardiol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"8D","DOI":"10.1016\/S0002-9149(99)80485-8","article-title":"Role of angiotensin II and prostaglandin E2 in regulating cardiac fibroblast collagen turnover","volume":"76","author":"CG Brilla","year":"1995","journal-title":"Am J Cardiol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.plefa.2011.01.003","article-title":"Prostaglandin E2 increases cardiac fibroblast proliferation and increases cyclin D expression via EP1 receptor","volume":"84","author":"P Harding","year":"2011","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.biocel.2012.03.013","article-title":"Prostaglandin F2alpha facilitates collagen synthesis in cardiac fibroblasts via an F-prostanoid receptor\/protein kinase C\/Rho kinase pathway independent of transforming growth factor beta1","volume":"44","author":"WY Ding","year":"2012","journal-title":"Int J Biochem Cell Biol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"4716","DOI":"10.1021\/bi036189j","article-title":"Structure of human epoxide hydrolase reveals mechanistic inferences on bifunctional catalysis in epoxide and phosphate ester hydrolysis","volume":"43","author":"GA Gomez","year":"2004","journal-title":"Biochemistry"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"E375","DOI":"10.1152\/ajpendo.00131.2009","article-title":"Alteration in plasma testosterone levels in male mice lacking soluble epoxide hydrolase","volume":"297","author":"A Luria","year":"2009","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"36592","DOI":"10.1074\/jbc.M806315200","article-title":"Opposite regulation of cholesterol levels by the phosphatase and hydrolase domains of soluble epoxide hydrolase","volume":"283","author":"AE EnayetAllah","year":"2008","journal-title":"J Biol Chem"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1093\/cvr\/cvr267","article-title":"N-terminal domain of soluble epoxide hydrolase negatively regulates the VEGF-mediated activation of endothelial nitric oxide synthase","volume":"93","author":"HH Hou","year":"2012","journal-title":"Cardiovasc Res"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.bbrc.2012.02.108","article-title":"Role of soluble epoxide hydrolase phosphatase activity in the metabolism of lysophosphatidic acids","volume":"419","author":"C Morisseau","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"38875","DOI":"10.1074\/jbc.M212481200","article-title":"Modulation of pro-inflammatory gene expression by nuclear lysophosphatidic acid receptor type-1","volume":"278","author":"F Gobeil Jr","year":"2003","journal-title":"J Biol Chem"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1194\/jlr.M017822","article-title":"COX-2-dependent and -independent biosynthesis of dihydroxy-arachidonic acids in activated human leukocytes","volume":"53","author":"N Tejera","year":"2012","journal-title":"J Lipid Res"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s00059-002-2354-y","article-title":"Cardiac fibrosis as a cause of diastolic dysfunction","volume":"27","author":"BS Burlew","year":"2002","journal-title":"Herz"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jacc.2006.01.077","article-title":"Alterations in the pattern of collagen deposition may contribute to the deterioration of systolic function in hypertensive patients with heart failure","volume":"48","author":"B Lopez","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"5618","DOI":"10.1073\/pnas.1221972110","article-title":"Unique mechanistic insights into the beneficial effects of soluble epoxide hydrolase inhibitors in the prevention of cardiac fibrosis","volume":"110","author":"P Sirish","year":"2013","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0094092","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T02:21:54Z","timestamp":1588990914000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0094092"}},"subtitle":[],"editor":[{"given":"Gangjian","family":"Qin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,4,9]]},"references-count":48,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2014,4,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0094092","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,9]]}}}